Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

The new nanoparticles could improve melanoma treatment by working better than current options.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Dr. Marina Kovalevsky and her daughter were hospitalized for suspected politically motivated thallium poisoning in Moscow.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

A patient's grey hair regained color during treatment with adalimumab.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.